Switch theme
Sign up to access all valuation multiples
The Searle Co Ltd is a pharmaceutical company. It is principally engaged in the manufacture of pharmaceutical and other consumer products. The company manufactures pharmaceutical products like Hydryllin, Extor, Nuberol, Forte, Peditral, Selanz SR, Tramal, and other products. Its pharmaceutical product range covers the therapeutic areas of cardiovascular, antibiotics, nutrition, respiratory care, gastroenterology, oncology, hepatology, neurology and psychiatry, probiotics, antibiotics, and nutritional care.
1965
3.0K+
LTM Revenue n/a
LTM EBITDA n/a
$220M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Searle Co. has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Searle Co. achieved revenue of $105M and an EBITDA of $20.4M.
Searle Co. expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Searle Co. valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $121M | $105M | XXX | XXX | XXX |
| Gross Profit | $46.9M | $47.3M | XXX | XXX | XXX |
| Gross Margin | 39% | 45% | XXX | XXX | XXX |
| EBITDA | $20.1M | $20.4M | XXX | XXX | XXX |
| EBITDA Margin | 17% | 19% | XXX | XXX | XXX |
| Net Profit | $8.4M | $1.1M | XXX | XXX | XXX |
| Net Margin | 7% | 1% | XXX | XXX | XXX |
| Net Debt | $67.1M | $68.8M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Searle Co.'s stock price is PKR 97 (or $0).
Searle Co. has current market cap of PKR 49.6B (or $177M), and EV of PKR 61.7B (or $220M).
See Searle Co. trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $220M | $177M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Searle Co. has market cap of $177M and EV of $220M.
Searle Co.'s trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Searle Co.'s 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Searle Co. and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $220M | XXX | XXX | XXX |
| EV/Revenue | 2.1x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | XXX | XXX |
| P/E | -65.6x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSearle Co.'s NTM/LTM revenue growth is Infinity%
Searle Co.'s revenue per employee for the last fiscal year averaged $35K, while opex per employee averaged $11K for the same period.
Over next 12 months, Searle Co.'s ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Searle Co.'s 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Searle Co. and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -13% | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | 1% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $35K | XXX | XXX | XXX | XXX |
| Opex per Employee | $11K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 16% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 32% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Searle Co. acquired XXX companies to date.
Last acquisition by Searle Co. was XXXXXXXX, XXXXX XXXXX XXXXXX . Searle Co. acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Searle Co. founded? | Searle Co. was founded in 1965. |
| Where is Searle Co. headquartered? | Searle Co. is headquartered in Pakistan. |
| How many employees does Searle Co. have? | As of today, Searle Co. has 3.0K+ employees. |
| Is Searle Co. publicy listed? | Yes, Searle Co. is a public company listed on KAR. |
| What is the stock symbol of Searle Co.? | Searle Co. trades under SEARL ticker. |
| Who are competitors of Searle Co.? | Similar companies to Searle Co. include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Searle Co.? | Searle Co.'s current market cap is $177M |
| What is the current revenue growth of Searle Co.? | Searle Co. revenue growth between 2023 and 2024 was -13%. |
| Is Searle Co. profitable? | Yes, Searle Co. is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
